DRUG STUDY

GENERIC DATE DOSAGE, INDICATION ACTION CLASSIFICATION NURSING

NAME/ ORDERED ROUTE, RESPONSIBILTY
BRAND NAME FREQUENCY
Metronidazole 9/28/9 500 mg, PO, Prevention of post Bactericidal: Amebicide >know the 10 rights in drug
TID operative infection inhibits DNA Antiprotozoal administration.
synthesis in Antibiotic >assess for allergic
specific Antibacterial reactions: rash, urticaria,
anaerobes, and pruritus.
causing cell >give oral form with meals.
death; >Assess patient's and
antiprotozoal family's knowledge of drug
trichomonacidal, therapy.
amebicidal.
Bisacodyl 9/28/9 1 tab, PO, HS Used to treat Increases Gastrointestinal >know the 10 rights in drug
constipation otr to peristalsis & drugs- laxatives administration.
clean out the motor activities >monitor frequency &
intestinal tract of the small character of stool.
before bowel intestines by >monitor occurrence of
examination or acting directly adverse reaction.
bowel surgery. on the smooth >swallow the tablet whole,
muscles. do not crush or chew.
>Assess patient's and
family's knowledge of drug
therapy.
Bisacodyl 9/28/9 1 supp, HS Used to treat Increases Gastrointestinal >know the 10 rights in drug
constipation otr to peristalsis & drugs- laxatives administration.
clean out the motor activities >monitor frequency &
intestinal tract of the small character of stool.
before bowel intestines by >monitor occurrence of
examination or acting directly adverse reaction.
bowel surgery. on the smooth >Assess patient's and
muscles. family's knowledge of drug
 therapy.
Cefuroxime 9/28/9 750 mg, IVP, Peri operative Cefuroxime, like Anti infectives >know the 10 rights in drug
q1 prior to OR prophylaxis the penicillins, is antibiotic administration.
a beta lactam Second generation >Before administration, ask
antibiotic.by cephalosporin patient if he is allergic to
binding to penicillin or cephalosporins.
specific >assess for skin sensitivity
penicillin- tests before therapy.
binding proteins >discontinue if
located inside hypersensivity occurs.
the bacterial cell >Assess patient's and
wall, it inhibits family's knowledge of drug
the third and last therapy.
stage of bacterial
cell wall
synthesis.
Cefuroxime 9/29/9 750 mg, IVP, Post operative Cefuroxime, like Anti infectives >know the 10 rights in drug
q8 prophylaxis the penicillins, is antibiotic administration.
a beta lactam Second generation >Before administration, ask
antibiotic.by cephalosporin patient if he is allergic to
binding to penicillin or cephalosporins.
specific >assess for skin sensitivity
penicillin- tests before therapy.
binding proteins >discontinue if
located inside hypersensivity occurs.
the bacterial cell >Assess patient's and
wall, it inhibits family's knowledge of drug
the third and last therapy.
stage of bacterial
cell wall
synthesis.
Metronidazole 9/29/9 500mg, IV Prophylaxis for Bactericidal: >know the 10 rights in drug
infusion, q8 surgery. inhibits DNA administration.
synthesis in >Assess patient's infectin
 specific before therapy and regularly
anaerobes, thereafter to monitor the
causing cell drug's effectiveness.
death; >IV infusion may cause
antiprotozoal thrombophlebitis; observe
trichomonacidal, closely.
amebicidal.
>Assess patient's and
family's knowledge of drug
therapy.
Ketorolac 9/29/9 50mg, IVP, q6 Management of Possesses anti- Non Steroidal Anti- >know the 10 rights in drug
severe, acute pain inflammatory, Inflammatory Drug administration.
in adults that anlagesics and (NSAID) >infuse slowly no less than
requires analgesia antipyretic 15 seconds.
and the opiate effects. >Assess patient's and
level, usually in family's knowledge of drug
postoperative therapy.
setting.
Omeprazole 9/29/9 40mg, IVP q12 Syptomatic Gastric acid- Proton pump >know the 10 rights in drug
x 2 doses gastroesophageal pump inhibitor: inhibitor administration.
reflux disease. suppresses >Monitor therapeutic
gastric acid effectiveness and adverse
secretion by reactions at the beginning of
specific the therapy and periodically
inhibition of the throughout the therapy.
hydrogen/potassi >assess knowledge/teach
um ATPase appropriate use of this
enzyme system medication, interventions to
at the secretory reduce side effects, and
surface of the other symptoms to report.
gastric parietal >Assess patient's and
cells; blocks the family's knowledge of drug
final step of acid therapy.
production.
Source: Nurse's Drug Handbook by George R. Spratti & Adrienne L. Woods
PATIENT AND HER CARE
MEDICAL MANAGEMENT
IV FLUIDS DATE ORDERED GEN.DESCRIPTION INDICATION CLIENT'S INITIAL NURSING
REACTION TO THE RESPONSIBILTY
TREATMENT
PLRS 1L 9/28/9 Each 100 ml contains Isotonic intravenous No allergic signs. >regulate and monitor
NaCl 900 mg. Ph 4.5- fluid electrolytes IV fluid as doctor's
7.0 adjusted with replacement solution. order.
hydrochloric acid. >assess functure site
for swelling.
>explain significance
of IV theraphy.
>assess
hypersensitivity.
>reinsert IV catheter
after 3 days to prevent
infection.

D5LR 1L 9/29/9 Each 100 ml contains For replace meat and No allergic signs. >explain to the client
5g of dextrose the fluid and and significant others
monohydrate 600mg electrolytes. the indications of IV
of sodium lactate & therapy.
hydrias 30mg. >maintain sterile
Potassium chloride technique to prevent
and 20mg of Calcium bacterial
Chloride dehydrate. contamination.
>record reading on
the fluid absorbed in
the hour rate flow.
PNSS 1L 9/29/9 Food supplement Resembles blood No allergic signs. >can cause
serum no free water hyperkalemia,
rehydration burns, hypernatermia
dehydration, >contraindicated with
salicylate overdose, liver disease.
diabetic ketoacidosis.